These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8988240)

  • 1. Selective endocytosis of fluorothymidine and azidothymidine coupled to LDL into HIV infected mononuclear cells.
    Mankertz J; Matthes E; Rokos K; von Baeyer H; Pauli G; Riedel E
    Biochim Biophys Acta; 1996 Dec; 1317(3):233-7. PubMed ID: 8988240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell specific uptake of antiretroviral drugs: AZT coupled to LDL inhibits HIV replication in human macrophages.
    Mankertz J; von Baeyer H; Rokos K; Nündel M; Pauli G; Riedel E
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):85-8. PubMed ID: 7757316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic inhibition of human immunodeficiency virus replication in vitro by combinations of 3'-azido-3'-deoxythymidine and 3'-fluoro-3'-deoxythymidine.
    Harmenberg J; Akesson-Johansson A; Vrang L; Cox S
    AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1197-202. PubMed ID: 1701316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent coupling of nucleosides to low density lipoprotein (LDL) generates macrophage specific (drug)-carriers.
    von Baeyer H; Neitzel H; Nündel M; Riedel E; Schultis HK
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):382-6. PubMed ID: 8225683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
    J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of LDL and acetylated LDL endocytosis by mononuclear cells in HIV infection.
    Juompan L; Puel J; Fournié GJ; Benoist H
    Biochim Biophys Acta; 1995 Aug; 1272(1):21-8. PubMed ID: 7545009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants.
    Kim EY; Vrang L; Oberg B; Merigan TC
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):401-7. PubMed ID: 11282008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of nucleoside-LDL-conjugates for the study of cell-selective internalization: stability characteristics and receptor affinity.
    Schultis HW; von Baeyer H; Neitzel H; Riedel E
    Eur J Clin Chem Clin Biochem; 1991 Oct; 29(10):665-74. PubMed ID: 1764541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages.
    Jorajuria S; Dereuddre-Bosquet N; Becher F; Martin S; Porcheray F; Garrigues A; Mabondzo A; Benech H; Grassi J; Orlowski S; Dormont D; Clayette P
    Antivir Ther; 2004 Aug; 9(4):519-28. PubMed ID: 15456083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.
    Fridkin M; Tsubery H; Tzehoval E; Vonsover A; Biondi L; Filira F; Rocchi R
    J Pept Sci; 2005 Jan; 11(1):37-44. PubMed ID: 15635725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative RNA and DNA gene amplification can rapidly monitor HIV infection and antiviral activity in cell cultures.
    Winters MA; Holodniy M; Katzenstein DA; Merigan TC
    PCR Methods Appl; 1992 May; 1(4):257-62. PubMed ID: 1477661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antiviral action of ribonucleotide reductase inhibitors and 3'-azido-3'-deoxythymidine on HIV type 1 infection in vitro.
    Giacca M; Borella S; Calderazzo F; Bianchi LC; D'Agaro P; Rampazzo C; Bianchi V; Reichard P
    AIDS Res Hum Retroviruses; 1996 May; 12(8):677-82. PubMed ID: 8744578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
    J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanogel-Conjugated Reverse Transcriptase Inhibitors and Their Combinations as Novel Antiviral Agents with Increased Efficacy against HIV-1 Infection.
    Senanayake TH; Gorantla S; Makarov E; Lu Y; Warren G; Vinogradov SV
    Mol Pharm; 2015 Dec; 12(12):4226-36. PubMed ID: 26565115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
    Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
    Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospects in the treatment of AIDS. II. AZT and related compounds; practical conclusions].
    Grieb P
    Pol Arch Med Wewn; 1992; 87(4-5):316-23. PubMed ID: 1381825
    [No Abstract]   [Full Text] [Related]  

  • 18. Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains.
    Yu F; Li W; Wang L; Dai Y; Lu X; Wang Q; Xie L; Jiang S
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30004408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of 3-hydroxy-3-phenylpropanoate ester–AZT conjugates as potential dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors.
    Manyeruke MH; Olomola TO; Majumder S; Abrahams S; Isaacs M; Mautsa N; Mosebi S; Mnkandhla D; Hewer R; Hoppe HC; Klein R; Kaye PT
    Bioorg Med Chem; 2015 Dec; 23(24):7521-8. PubMed ID: 26775541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of anti-HIV activity of azidothymidine and fluorothymidine 5'-phosphonates].
    Mamaeva OA; Pliasunova OA; Pokrovskiĭ AG; Diatkina NB; Arzumanova AA
    Mol Biol (Mosk); 1994; 28(1):137-42. PubMed ID: 8145741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.